Modafinil ADHD Marketing Plans Include DTC After First Year
This article was originally published in The Pink Sheet Daily
Executive Summary
Cephalon's promotional plans for the attention deficit/hyperactivity disorder treatment modafinil (formerly Attenace) include direct-to-consumer ads after the product's first year on the market